엑소자임스(EXOZ)는 NAS에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $6.44 (+3.96%), 시가총액 $79.70M.
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
엑소자임스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
엑소자임스의 현재 주가는 $6.44 (+3.96%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
엑소자임스의 시가총액은 약 $79.70M입니다.
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing.